Biocept (NASDAQ:BIOC) changed -0.92% to recent value of $5.36. The stock transacted 582804 shares during most recent day however it has an average volume of 694.00K shares. It spotted trading -58.77% off 52-week high price. On the other end, the stock has been noted 153.79% away from the low price over the last 52-weeks.
On Dec. 14, 2020, Biocept (NASDAQ:BIOC) a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, reported that it has received more than 150,000 samples for COVID-19 RT-PCR testing to date and has continued to report the vast majority of results to customers within 48 hours of receiving a sample. The Company also announces the successful relocation to its new corporate headquarters and molecular laboratory facility in San Diego.
All clinical operations at the new facility are fully functioning, including our newly designed state-of-art CLIA-certified and CAP-accredited laboratory. We are pleased with the smooth transition, and our ability to seamlessly continue serving physicians and patients with both oncology and COVID-19 testing, said Biocept CFO and SVP of Operations Tim Kennedy. Our new facility was designed specifically to align with our commercial, development and administrative needs, with the bonus of an expected 20% annualized reduction in rent and other facility costs.
BIOC has a gross margin of -32.30%. Its earnings per share (EPS) expected to touch remained 86.40% for this year while earning per share for the next 5-years is expected to reach at 40.00%.
The company has 13.40M of outstanding shares and 12.49M shares were floated in the market. According to the most recent quarter its current ratio was 2.9 that represents company’s ability to meet its current financial obligations. The price moved ahead of 12.38% from the mean of 20 days, 13.67% from mean of 50 days SMA and performed 2.27% from mean of 200 days price. Company’s performance for the week was 10.52%, -12.99% for month and YTD performance remained 87.41%.